Adaptive Sample Size Re-Estimation: Methods, Risks and Regulatory Views
Adaptive Sample Size Re-Estimation: Methods, Risks and Regulatory Views Adaptive sample size re-estimation has become an increasingly prominent strategy in the conduct of clinical trials, particularly in the realms of gilead clinical trials and other adaptive trial designs. This comprehensive guide will provide clinical operations, regulatory affairs, and medical affairs professionals in the US, UK,…
Read More “Adaptive Sample Size Re-Estimation: Methods, Risks and Regulatory Views” »